Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Gynecologic Oncology

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/GYNO.1999.5463PMID 10479491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.

  1996cited by this paper
• Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.

  1996cited by this paper
• A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

  1995cited by this paper
• BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT

  1995cited by this paper
• Aminothiadiazole in the Treatment of Advanced Leiomyosarcoma of the Uterine Corpus: A Gynecologic Oncology Group Study

  1995cited by this paper
• Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

  1994cited by this paper
• Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

  1994cited by this paper
• Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group study

  1992cited by this paper
• Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

  1992cited by this paper
• A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus

  1991cited by this paper
• Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.

  1991cited by this paper
• Mitoxantrone in the Treatment of Advanced Uterine Sarcoma: A Phase II Trial of the Gynecologic Oncology Group

  1990cited by this paper
• Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

  1989cited by this paper
• Pure mesenchymal neoplasms of the uterine corpus: selected problems.

  1988cited by this paper
• Mesenchymal Tumors of the Uterus

  1987cited by this paper
• Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.

  1987cited by this paper
• Cisplatin as Second‐Line Chemotherapy in the Treatment of Advanced or Recurrent Leiomyosarcoma of the Uterus A Phase II Trial of the Gynecologic Oncology Group

  1986cited by this paper
• Estrogen and Progesterone Receptors in Uterine Sarcomas

  1986cited by this paper
• Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin Versus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)

  1985cited by this paper
• Chemotherapy of gynecologic cancer

  1984cited by this paper
• Surgery for pulmonary metastasis: a 20-year experience.

  1984cited by this paper
• A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

  1983cited by this paper

• Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta‐analysis, and meta‐regression analysis

  2023cites this paper
• Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP)

  2020cites this paper
• Uterine Cancer

  2020cites this paper
• Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019).

  2019cites this paper
• Copper ions are novel therapeutic agents for uterine leiomyosarcoma.

  2019cites this paper
• 6 – Sarcoma of the Uterus

  2018cites this paper
• Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

  2018cites this paper
• Systemic treatment in adult uterine sarcomas.

  2018cites this paper
• Nonendometrioid Endometrial Carcinomas and Uterine Sarcomas

  2017cites this paper
• Heterogene Malignome erfordern differenzierte Therapiestrategien

  2016cites this paper
• Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.

  2016cites this paper
• Prognostic factors and survival in patients treated surgically for primary and recurrent uterine leiomyosarcoma: a single center experience.

  2015cites this paper
• Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)

  2015cites this paper
• Pharmacological treatment for uterine leiomyosarcomas

  2015cites this paper
• A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group Study.

  2014cites this paper
• A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.

  2014cites this paper
• Advances in the diagnosis and treatment of uterine sarcomas.

  2014cites this paper
• Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan

  2014cites this paper
• [Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].

  2013cites this paper
• Superficial Leiomyosarcoma of the Glans: Report of a Case and Literature Review

  2013cites this paper
• A Review of Treatment of Uterine Leiomyosarcomas

  2013cites this paper
• Primary leiomyosarcoma of the penis

  2013cites this paper
• Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma

  2012cites this paper
• A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.

  2012cites this paper
• Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy

  2012cites this paper
• Diagnosis and management of leiomyosarcoma arising from ovarian vein: Case report and literature review

  2012cites this paper
• A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma

  2012cites this paper
• Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line

  2012cites this paper
• Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma

  2012cites this paper
• Identifying and Targeting Molecular Deregulations in Uterine Leiomyosarcoma: A Role for mTOR Inhibition-Based Combination Therapies

  2012cites this paper
• Nonendometrioid Endometrial Carcinomas and Uterine Sarcomas

  2012cites this paper
• Leiomyosarcomas of Uterus

  2011influential citation
• Uterine sarcomas--recent progress and future challenges.

  2011cites this paper
• Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.

  2011cites this paper
• The treatment of uterine leiomyosarcoma: clinical outcomes of 18 cases and the effectiveness of chemotherapy.

  2011cites this paper
• Reed Uterine Carcinosarcomas

  2011cites this paper
• Optimal management of uterine leiomyosarcoma

  2010cites this paper
• Complete remission with intraperitoneal cisplatin followed by prolonged oral etoposide in a stage IIIc primary leiomyosarcoma of the fallopian tube patient

  2010cites this paper
• A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.

  2010cites this paper
• Chemotherapy for gynecologic cancers.

  2009cites this paper
• Uterine sarcomas - an evaluation of treatment results and prognostic factors

  2009cites this paper
• Management of uterine leiomyosarcoma: an update

  2009cites this paper
• Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

  2009cites this paper
• Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

  2008cites this paper
• Uterine sarcoma: a report of 57 cases over a 16-year period analysis.

  2008cites this paper
• Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

  2008cites this paper
• The management of uterine sarcomas.

  2008cites this paper
• Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.

  2007cites this paper
• Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls

  2007cites this paper
• Uterine Sarcomas: Therapeutic Approach, Prognostic and Epidemiologic Factors Evaluation: a Prospective Clinical Study of 36 Cases

  2007cites this paper
• [Chemotherapy of sarcomas: optimization of existing drugs and new molecules].

  2006cites this paper
• Multimodality therapy in uterine sarcoma

  2006cites this paper
• Concurrent Radiochemotherapy of Locally Recurrent or Advanced Sarcomas of the Uterus

  2006cites this paper
• High dose ifosfamide plus doxorubicin for advanced or metastatic gynecologic sarcomas

  2006cites this paper
• La chimiothérapie des sarcomes : optimisation des substances existantes et nouvelles molécules

  2006cites this paper
• Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortium.

  2006cites this paper
• Malignant transformation of myomas: myth or reality?

  2006cites this paper
• A retrospective review of metastatic or recurrent uterine sarcomas treated with ifosfamide and doxorubicin (IMA).

  2006cites this paper
• Soft-tissue and bone sarcomas.

  2005cites this paper
• Chemotherapy for Uterine Cancer

  2005cites this paper
• The role of surgery and treatment trends in uterine sarcoma.

  2005cites this paper
• Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

  2005cites this paper
• Systemic therapy for advanced uterine sarcoma: a systematic review of the literature.

  2005influential citation
• Response to “Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma”

  2004cites this paper
• The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital.

  2004cites this paper
• Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma

  2004cites this paper
• Management of Uterine Sarcomas

  2004cites this paper
• Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.

  2004cites this paper
• Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults

  2004cites this paper
• Chapter 22 – Primary Treatment of Uterine Sarcomas

  2004cites this paper
• Chapter 23 – Treatment of Recurrent Uterine Sarcomas

  2004cites this paper
• Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.

  2003cites this paper
• Metastatic Soft Tissue Sarcoma in Adults

  2003cites this paper
• Adjuvant chemotherapy following surgery in the management of uterine sarcomas.

  2003cites this paper
• Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.

  2003cites this paper
• Leiomyosarcoma of the cervix.

  2003cites this paper
• Leiomyosarcoma of the Penis

  2002cites this paper
• Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.

  2002cites this paper
• Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment.

  2002cites this paper
• Uterine sarcomas--the biggest challenge?

  2002cites this paper
• Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.

  2002cites this paper
• Gynaecology Retrospective Study of Management of Uterine Sarcomas at Oxford 1990-1998: Role of Adjuvant Treatment

  2002cites this paper
• Contrast of Response to Dacarbazine, Mitomycin, Doxorubicin, and Cisplatin (DMAP) Plus GM-CSF Between Patients with Advanced Malignant Gastrointestinal Stromal Tumors and Patients with Other Advanced Leiomyosarcomas

  2002cites this paper
• Diagnostik und Therapie der Uterussarkome

  2002cites this paper
• Adjuvant chemotherapy in early stage uterine sarcomas: an open question.

  2001cites this paper
• Radiosensitization in sarcoma cell lines with a p53 missense mutation correlates with prevention of irradiation G2/M arrest but not with induction of apoptosis.

  2001cites this paper
• A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.

  2000cites this paper
• Chemotherapy for malignant mixed Müllerian tumors of the ovary.

  2000cites this paper
• Present knowledge of gynecologic sarcoma management.

  1999cites this paper